期刊
TOXICOLOGY AND APPLIED PHARMACOLOGY
卷 410, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.taap.2020.115359
关键词
Anacardic acid; Antitumoral; Immunomodulation; Leukopenia; Myelosuppression
资金
- National Council of Science and Technology of Mexico
- (CONACyT) [21067]
6-pentadecyl salicylic acid (6SA) shows effective antineoplastic activity against breast cancer cells by inducing caspase-8-mediated apoptosis, reducing tumor volume without decreasing tumor-infiltrated lymphocytes. Additionally, 6SA reduces lung metastasis, increases immune cell proportion in blood, lymph nodes, and bone marrow, including tumor-infiltrating NK cells and cytotoxic T lymphocytes. Treatment with 6SA also improves the antitumoral immunological microenvironment and overall survival of animals, without causing myelosuppression or immunosuppression like Taxol.
Many antineoplastic agents induce myelosuppression and leukopenia as secondary effects in patients. The development of anticancer agents that simultaneously provoke antitumor immune response represents an important therapeutic advance. The administration of 6-pentadecyl salicylic acid (6SA) contributes to the antitumor immunity using 4T1 breast cancer cells in Balb/c female mice, with Taxol as a positive control and in cotreatment with 6SA (6SA + Taxol; CoT). Our results show that 6SA reduces tumor volume and size by inducing caspase-8-mediated apoptosis without reducing tumor infiltrated lymphocytes. Also, 6SA reduced lung metastasis and increased the proportion of immune cells in blood, lymph nodes and bone marrow; more evidently, in the proportion of tumor-infiltrated natural killer (NK) cells and cytotoxic T lymphocytes. Taxol reduces helper and cytotoxic lymphocytes causing systemic immunosuppression and myelosuppression in bone marrow, whereas 6SA does not decrease any immune cell subpopulations in circulating blood and lymph nodes. More importantly, the CoT decreased the Taxol-induced cytotoxicity in circulating T cells and bone marrow. Treatment with 6SA increases the secretion of IL-2, IL-12, GM-CSF, TNF-alpha and IFN-gamma and significantly reduces IL-10 and IL-17 secretion, suggesting that the reduction of regulatory T cells and tumor-associated macrophages contribute to the host control of tumor development. Finally, 6SA has an effective antineoplastic activity against breast cancer cells in an immunocompetent animal, reduces the myelosuppression and leukopenia that Taxol produces, improves the antitumoral immunological microenvironment and increases the overall survival of the animals improving the quality of life of patients with cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据